产品名称 OTX 008 - PTX 008 | Calixarene 0118
产品货号 Axon 2332 CAS [286936-40-1] MF C52H72N8O8MW 937.18 Purity: 99% Soluble in DMSO and Ethanol Description Selective allosteric inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumor angiogenesis. OTX008 inhibited galectin-1 expression and ERK1/2 and Akt-dependent survival pathways, and induced G2/M cell cycle arrest through CDK1. References Certificates Categories Extra info L. Astorgues-Xerri et al. OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis. Eur. J. Cancer. 2014, 50, 2463-2477.   M. Zucchetti et al. Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib. Cancer Chemother. Pharmacol. 2013, 72, 879-887.   R.O. Dings et al. Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer. Invest. New Drugs. 2013, 31, 1142-1150.   R.P. Dings et al. Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding. J. Med. Chem. 2012, 55, 5121-5129. Certificate of Analysis Material Safety Data Sheet Angiogenesis Apoptosis Cell Cycle Regulation Cell Signaling & Oncology Immunology PI3K-Akt-mTOR Galectin Selective allosteric inhibitor of galectin-1 Chemical name 2,2',2'',2'''-[Pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-5,11,17,23-tetrayltetrakis(oxy)]tetrakis[N-[2-(dimethylamino)ethyl]-acetamide Parent CAS No. [286936-40-1] Order Size Unit Price Stock 5 mg €125.00 In Stock
产品价格 现货询价,电话:010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

OTX 008 - PTX 008 | Calixarene 0118

Based on 9 publications in PubMed 10 10 9

Axon 2332

CAS [286936-40-1]

MF C52H72N8O8
MW 937.18

  • Purity: 99%
  • Soluble in DMSO and Ethanol

OTX 008

Description

Selective allosteric inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumor angiogenesis. OTX008 inhibited galectin-1 expression and ERK1/2 and Akt-dependent survival pathways, and induced G2/M cell cycle arrest through CDK1.
产品资料